OPINION: Being Don Draper

Courtesy TheMarkNews.com

Got a mental picture of Don Draper? I look almost exactly like him. Just make him bald. Give him a grey beard. Weaken his chin considerably, then add a whole bunch of wrinkles.

Make him three, maybe four inches shorter, and roughly 40 pounds heavier (pretty much all of it in the stomach). Oh, and don’t forget to lose the suit. Picture your new Don Draper in khakis and a wine-stained polo shirt from Giant Tiger.

But you can keep his smokes. I smoke. A lot. Just like Don.

Okay, so I don’t look much like him. Big deal. But I was the creative director of an ad agency. And I’m taciturn as hell.

As for the shenanigans? Alas, I arrived a little late to the party, missing the in-office drinking and inter-mural sexual activity (although I did catch the tail end of the mandatory cigarette-smoking policy). That’s not to say people weren’t drinking and getting laid during office hours. Just that by the time I’d arrived, a wafer-thin veneer of propriety was in place.

But after all, those were the ’80s – the years that put the decade in decadence. And by then, of course, cocaine had become the fuel of choice for creative departments. (Imagine the sight of Peter Campbell on a three-day coke bender.)

Like Don’s, my job was to come up with ideas. Unlike Don, I was rarely able to produce them out of thin air on cocktail napkins between multiple sexual conquests. I did it at a desk. Boring, I know.

I also came a little late to the Mad Men party. Didn’t really pay attention until the third season, when suddenly Sterling Cooper was in play. The buying-back of Sterling Cooper is my favourite part of the show. I wish we’d seen some more of the machinations these things always produce.

The buying and selling of ad agencies was fairly uncommon in Draper’s day, but in the ’80s and ’90s it became the norm. It seemed everyone was either buying or selling something.

We were reluctant entrepreneurs. Our agency was for sale the day we opened our doors. And there was no shortage of suitors. For a time, it seemed everybody in town was hell-bent on buying us or merging us, and it was fun to feel wanted.

One day, the president of the Canadian branch of a large U.S. firm took us to lunch. We made small talk for several minutes, and then ordered some food. As the waiter left, our host looked around to ensure no one was eavesdropping. This was, after all, an extremely delicate and confidential matter that could impact several dozen people’s lives.

Then, with quiet pride, he boasted: “I got the whole thing down on a single piece of paper! A paragraph!”

He dramatically reached inside his jacket. No paper. Then the other pocket. No paper. “Oh my god!” he said. “Where the hell is it?”

He searched frantically under our napkins and behind our plates and beside our glasses. He even checked under the table cloth.

Suddenly, he realized that he must have put the paper inside the menu he’d held. Distraught, he leapt from the table to the hostess station and began frenetically sorting through the stack of menus there. It was quite a spectacle.

Needless to say, that marriage was over before it began.

The Mad Men storyline is remarkably similar to our experience, only backwards. We started as a scrappy little shop of three people, but we grew and grew until we could live every Canadian’s dream: We sold to the Americans. Yup, bought by New York. But then New York sold us to Chicago. And then Chicago flipped us to Paris, which at least allowed us to buy the place back in an office overlooking the Arc de Triomphe on the Champs-Elysées.

For the most part, I find Mad Men very faithful to the ad business and Don Draper to be the greatest character created in this millennium. I hope the show plays itself out to the end of the 1960s. At what point, for example, did it become not OK for men to talk to women the way they do in Mad Men? When did someone say, “Maybe it’s not a great idea to be plastered for a client meeting at 10 in the morning?” When did it become inappropriate to drive with a tumbler of rye in your hand? Who finally said, “Okay, Peter Campbell’s a toad, let’s fire his ass?”

As for my doppelganger? How long did Don keep it together? Does he even have an entire season in him? Exactly how much of an enigma can one man become?

I don’t know. But I do know this: for me, the stress never got to the point where I paid somebody to slap me. I swear to God.

The Mark News is Canada’s online forum for opinion and analysis.

Keep it Factual
Add CityNews Toronto as a trusted source on Google to see more local stories from us.

Top Stories

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of Ozempic and other GLP-1 drugs, traditionally used to manage Type 2 diabetes, has exploded in recent years thanks to their weight-loss side effects. And as cheaper, generic versions become more widely available, uptake is only expected to rise further. Semaglutides, or GLP-1s as they're sometimes called, are the active ingredient in drugs like Ozempic. For grocers that have pharmacy units, signs of that growth are already noticeable in their financial reports. Loblaw Cos. Ltd., which owns Shoppers Drug Mart and Pharmaprix, reported a roughly 40 per cent surge in GLP-1 sales in each of its last two quarters. "We are beginning to see the impact of GLP-1 drugs going generic. It's still very early, but the initial indications are encouraging," Per Bank, chief executive of Loblaw, told analysts on an earnings call in July. Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027. Metro Inc.'s outgoing chief executive, Eric La Flèche, struck a similar note during its earnings call last month. Metro owns Jean Coutu pharmacies. "Demand fundamentals remain strong with early evidence of increased patient adoption and higher prescription volumes," he said. Loblaw reported its drug retail same-store sales grew 4.6 per cent in its latest quarter, while Metro's pharmacy same-store sales were up 4.8 per cent. Both outpaced same-store sales metrics for food. The gains were driven by the prescriptions category. Even though generic versions of the drug mean lower prices, the growth in volume is still a net positive. "As generic supply continues to build, we expect ongoing expansion of the GLP-1 category to drive low-teens volume and contribution growth," La Flèche told analysts. That's "indicating that higher volumes should more than offset a meaningful portion of the price pressure from generalization," Veritas analyst Kathleen Wong said in a note about Metro's quarterly results in August. "The resulting price deflation is therefore likely to pressure pharmacy same-store sales measured in dollars, but Metro’s early experience suggests that increased accessibility and prescription volumes can offset part of that pressure at the contribution level." Health Canada has so far approved three generic semaglutide products, and is continuing to review more — making the country the first among G7 nations to do so. These used to be called the drug of the rich, said Amar Singh, senior director and head of Canadian retail insights at Kantar. "This drug was expensive, and now, with the generics coming out, this is increasing penetration as the cost has come down and more people can afford it," he said in an interview. Half of the respondents in a Leger poll from March said insurance coverage or a lower-cost generic would increase their likelihood of using a GLP-1. More than half cited weight loss as their primary reason for taking the drug. At that time, eight per cent — or three million Canadians — were on prescription GLP-1s, the survey suggested. With generics increasingly available in the market, Singh said he expects uptake to rise to about 20 per cent over the next year or two. That surge comes as Loblaw and Metro are expanding their pharmacy networks. Loblaw expects to have opened about 200 stores over the last three years, and roughly half are pharmacies, Wong said. Meanwhile, Empire acquired nine Morelli’s pharmacies in Ontario last month that are already situated within some Longo’s grocery stores. Jo-Ann McArthur, president of Nourish Food Marketing, said the increasing popularity of weight-loss drugs could be an opportunity for grocers to tailor customer experiences, especially as attitudes toward food change among weight-loss drug users. For instance, she said grocers could suggest GLP-1-friendly foods and offer meal planning through their loyalty apps, offer health-care insights for those on and off drugs, streamline store shelf labelling and market items that are weight-loss drug friendly. Late last year, Loblaw launched an online weight-management program for people to connect with health care practitioners and see if they qualify for the drugs. "Where they make more money (is) by providing more services and more advice and just making it easier for the consumer to just stay loyal," she said. And it's not just about keeping GLP-1 users within the same ecosystem. "People who are on these drugs often are controlling the whole family's shopping and meal prep," she said. "If one person in a family is on a diet, the whole family is on a diet." This report by The Canadian Press was first published Sept. 13, 2026.

2h ago

Top Stories

Weight-loss drugs shaping up to be a boon for grocers' pharmacy units

While discount stores have been a bright spot recently for major grocery chains, other units within their empires have been quietly seeing a sales boom: their pharmacies. And it's largely coming from rising sales of weight-loss drugs. The popularity of Ozempic and other GLP-1 drugs, traditionally used to manage Type 2 diabetes, has exploded in recent years thanks to their weight-loss side effects. And as cheaper, generic versions become more widely available, uptake is only expected to rise further. Semaglutides, or GLP-1s as they're sometimes called, are the active ingredient in drugs like Ozempic. For grocers that have pharmacy units, signs of that growth are already noticeable in their financial reports. Loblaw Cos. Ltd., which owns Shoppers Drug Mart and Pharmaprix, reported a roughly 40 per cent surge in GLP-1 sales in each of its last two quarters. "We are beginning to see the impact of GLP-1 drugs going generic. It's still very early, but the initial indications are encouraging," Per Bank, chief executive of Loblaw, told analysts on an earnings call in July. Loblaw executives are projecting double-digit growth for GLP-1 sales in 2027. Metro Inc.'s outgoing chief executive, Eric La Flèche, struck a similar note during its earnings call last month. Metro owns Jean Coutu pharmacies. "Demand fundamentals remain strong with early evidence of increased patient adoption and higher prescription volumes," he said. Loblaw reported its drug retail same-store sales grew 4.6 per cent in its latest quarter, while Metro's pharmacy same-store sales were up 4.8 per cent. Both outpaced same-store sales metrics for food. The gains were driven by the prescriptions category. Even though generic versions of the drug mean lower prices, the growth in volume is still a net positive. "As generic supply continues to build, we expect ongoing expansion of the GLP-1 category to drive low-teens volume and contribution growth," La Flèche told analysts. That's "indicating that higher volumes should more than offset a meaningful portion of the price pressure from generalization," Veritas analyst Kathleen Wong said in a note about Metro's quarterly results in August. "The resulting price deflation is therefore likely to pressure pharmacy same-store sales measured in dollars, but Metro’s early experience suggests that increased accessibility and prescription volumes can offset part of that pressure at the contribution level." Health Canada has so far approved three generic semaglutide products, and is continuing to review more — making the country the first among G7 nations to do so. These used to be called the drug of the rich, said Amar Singh, senior director and head of Canadian retail insights at Kantar. "This drug was expensive, and now, with the generics coming out, this is increasing penetration as the cost has come down and more people can afford it," he said in an interview. Half of the respondents in a Leger poll from March said insurance coverage or a lower-cost generic would increase their likelihood of using a GLP-1. More than half cited weight loss as their primary reason for taking the drug. At that time, eight per cent — or three million Canadians — were on prescription GLP-1s, the survey suggested. With generics increasingly available in the market, Singh said he expects uptake to rise to about 20 per cent over the next year or two. That surge comes as Loblaw and Metro are expanding their pharmacy networks. Loblaw expects to have opened about 200 stores over the last three years, and roughly half are pharmacies, Wong said. Meanwhile, Empire acquired nine Morelli’s pharmacies in Ontario last month that are already situated within some Longo’s grocery stores. Jo-Ann McArthur, president of Nourish Food Marketing, said the increasing popularity of weight-loss drugs could be an opportunity for grocers to tailor customer experiences, especially as attitudes toward food change among weight-loss drug users. For instance, she said grocers could suggest GLP-1-friendly foods and offer meal planning through their loyalty apps, offer health-care insights for those on and off drugs, streamline store shelf labelling and market items that are weight-loss drug friendly. Late last year, Loblaw launched an online weight-management program for people to connect with health care practitioners and see if they qualify for the drugs. "Where they make more money (is) by providing more services and more advice and just making it easier for the consumer to just stay loyal," she said. And it's not just about keeping GLP-1 users within the same ecosystem. "People who are on these drugs often are controlling the whole family's shopping and meal prep," she said. "If one person in a family is on a diet, the whole family is on a diet." This report by The Canadian Press was first published Sept. 13, 2026.

2h ago

Most Watched Today